PTC Therapeutics PTCT Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $833.99M-43.7% | $984.65M+26.3% | $672.62M+27.9% | $1.02B+55.4% | $1.48B+170% | ||
| $1.06B+93.5% | $960.72M+167% | $1.02B+108% | $971.76M+122% | $546.95M+62.6% | ||
| $219.92M+4.5% | $181.62M+14.5% | $203.07M+1.5% | $196.13M+4.8% | $210.5M+6.5% | ||
| $75.57M+249% | $79.65M+243% | $52.69M+47.7% | $34.06M+7.0% | $21.68M-27.9% | ||
| $2.25B-2.7% | $2.27B+66.5% | $2.01B+56.7% | $2.27B+67.4% | $2.32B+98.2% | ||
| $52.74M-11.3% | $55.37M-9.2% | $56.97M-9.8% | $57.19M-13.3% | $59.46M-35.9% | ||
| $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | $82.34M0.0% | ||
| $380.68M+221% | $388.75M+227% | $396.47M+20.0% | $143.81M-56.4% | $118.45M-64.1% | ||
| $2.87B+8.0% | $2.9B+70.0% | $2.64B+43.5% | $2.63B+37.5% | $2.66B+48.4% | ||
| $313.05M-1.5% | $381.27M+25.3% | $303.14M-9.9% | $338.95M0.0% | $317.81M-4.0% | ||
| $498K— | $2.04M— | $1.69M— | —— | —— | ||
| $286.94M+5,585% | $286.63M+9,454% | $286.32M+10,737% | $5.36M+134% | $5.05M+159% | ||
| $923.6M+55.1% | $968.43M+66.7% | $866.25M+41.8% | $627.81M+3.0% | $595.39M+3.6% | ||
| $3.05B+7.3% | $3.1B+10.7% | $2.8B-3.4% | $2.84B-1.9% | $2.84B+5.9% | ||
| $81K+3.8% | $80K+3.9% | $79K+3.9% | $78K+2.6% | $78K+2.6% | ||
| -$2.97B-6.7% | -$2.96B+18.7% | -$2.83B+21.0% | -$2.85B+18.1% | -$2.78B+17.6% | ||
| -$180.47M+2.9% | -$205.31M+81.3% | -$155.76M+85.2% | -$206.55M+78.9% | -$185.76M+79.2% | ||
| $2.87B+8.0% | $2.9B+70.0% | $2.64B+43.5% | $2.63B+37.5% | $2.66B+48.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are PTC Therapeutics's total assets?
- PTC Therapeutics (PTCT) holds $2.9B in total assets, up 8.1% year over year.
- How much debt does PTC Therapeutics have?
- PTC Therapeutics carries $395.1M in total debt against -$180.5M of shareholders' equity, a debt-to-equity ratio of 372.31.
- How much cash does PTC Therapeutics have?
- PTC Therapeutics holds $834.0M in cash and equivalents.
- Can PTC Therapeutics cover its short-term obligations?
- Its current ratio is 2.44 — current assets exceed current liabilities.
- Where does PTC Therapeutics's balance sheet data come from?
- Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
